BSE | NSE

Dr. Lal Pathlabs Ltd.

539524 LALPATHLAB Group (A)

26 Jul,15:50

3076.85
57.80 (1.91%)

HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist

Refresh

Zoom

Day

6Mn

Volume	Prev close	Day's H/L (Rs.)	52wk H/L (Rs.)	Mkt Cap (Rs. Cr)	Dr. Lal Pathlabs Ltd. BUY SELL
6,362	3,019.05	3,079.80 - 2,990.00	3,054.10 - 1,943.20	25,691.70	Dr. Lal Pathlabs Ltd. BUY SELL

News for Dr. Lal Pathlabs Ltd.

Dr Lal PathLabs Q2 Profit Up 54% to Rs 111 Cr

Dr Lal PathLabs reports a 54% increase in net profit for the second quarter, reaching Rs 111 crore. Revenue also saw a significant rise.

Nov 02, 2023 18:56

More News for Dr. Lal Pathlabs Ltd. »

(Rs. Crore)

Financial Results of Dr. Lal Pathlabs Ltd.

	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20
Sales	1,966.80	1,769.00	1,872.70	1,490.50	1,273.60
Operating profit	559.20	460.70	510.20	407.40	327.80
Interest	26.80	34.40	28.50	14.80	14.70
Gross profit	592.50	472.90	534.70	443.90	370.70
EPS (Rs)	46.04	35.06	41.31	33.63	26.79

See more in Research Center »

Statements:Balance Sheet | P&L | Cash Flow

More:Dividend | Bonus | Share Holding | Capital Structures | Ratios

About Dr. Lal Pathlabs Ltd.

Dr Lal PathLabs Limited is an Indian service provider of diagnostic and related healthcare tests. Based in New Delhi, the company offers tests on blood, urine and other human body viscera. Wikipedia

News for Pharmaceuticals and health care

Aditya Birla Group Targets USD 25 Billion Consumer Business Revenue

Aditya Birla Group aims to reach USD 25 billion in consumer business revenue in the next 5 years, driven by diversification and portfolio strengthening. The group is focused on financial services,...

Jul 26, 2024 22:32

Sebi Confirms Order Against 12 in V Marc India Fraud

Sebi confirms its order against 12 entities, including V Marc India's promoter, for a fraudulent scheme to manipulate stock prices.

Jul 26, 2024 22:25

PM GatiShakti Evaluates 5 Infra Projects: Road, Rail

Network Planning Group (NPG) has evaluated 5 infrastructure projects, including road and rail, under the PM GatiShakti initiative, focusing on integrated planning.

Jul 26, 2024 22:10

Fortune Wealth Targets Rs 500 cr Multi-Cap Fund

Fortune Wealth aims to raise Rs 500 crore for its multi-cap portfolio fund within 5 months. The fund, launched in June 2024, has already gathered Rs 320 crore.

Jul 26, 2024 22:05

Kargil Vijay Diwas: India Post Releases Commemorative Stamp

India Post commemorates the 25th anniversary of Kargil Vijay Diwas with a special postage stamp, honoring the bravery of Indian armed forces.

Jul 26, 2024 22:04

More News »

Top News

G20 Agrees to Tax Super-Rich, Brazil Leads Effort

Finance ministers from G20 nations agree to work toward taxing the super-rich, a significant step toward addressing global inequality. Brazil's proposal for a 2% minimum tax on billionaires is...

Jul 27, 2024 03:35

Aditya Birla Group Targets USD 25 Billion Consumer Business Revenue

Aditya Birla Group aims to reach USD 25 billion in consumer business revenue in the next 5 years, driven by diversification and portfolio strengthening. The group is focused on financial services,...

Jul 26, 2024 22:32

Sebi Confirms Order Against 12 in V Marc India Fraud

Sebi confirms its order against 12 entities, including V Marc India's promoter, for a fraudulent scheme to manipulate stock prices.

Jul 26, 2024 22:25

PM GatiShakti Evaluates 5 Infra Projects: Road, Rail

Network Planning Group (NPG) has evaluated 5 infrastructure projects, including road and rail, under the PM GatiShakti initiative, focusing on integrated planning.

Jul 26, 2024 22:10

Fortune Wealth Targets Rs 500 cr Multi-Cap Fund

Fortune Wealth aims to raise Rs 500 crore for its multi-cap portfolio fund within 5 months. The fund, launched in June 2024, has already gathered Rs 320 crore.

Jul 26, 2024 22:05

More Top News »

Report Card

PE Ratios

66.84

EPS (Rs.)

46.04

Sales (Rs. Cr)

479.00

Face Value (Rs.)

Net Profit Margin (%)

19.54

Last Bonus

Last Dividend(%)

Return on Average Equity

20.79

BSE Announcements from Dr. Lal Pathlabs Ltd. (See all)

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 - 08 Jul 2024

Closure of Trading Window - 26 Jun 2024

Compare 'Dr. Lal Pathlabs Ltd.' with other stocks

Sun Pharmaceutical Industries Ltd.
1,665.20
Compare

Cipla Ltd.
1,499.90
Compare

Divi's Laboratories Ltd.
4,549.75
Compare

Zydus Lifesciences Ltd.
1,205.60
Compare

Dr. Reddy's Laboratories Ltd.
6,854.20
Compare

Torrent Pharmaceuticals Ltd.
3,087.85
Compare

Apollo Hospitals Enterprise Ltd.
6,388.60
Compare

Max Healthcare Institute Ltd.
926.50
Compare

Lupin Ltd.
1,801.15
Compare

Alkem Laboratories Ltd.
5,178.80
Compare

Mutual Funds Invested

Goldman Sachs CNX 500 Fund - Direct Plan - Growth

0.03%

Goldman Sachs CNX 500 Fund - Growth

0.03%

Goldman Sachs CNX 500 Fund - Direct Plan - Dividend

0.03%

Goldman Sachs CNX 500 Fund - Dividend

0.03%

Most Active

Change (Rs.)

Cipla Ltd.
78.35
(5.22%)

Divi's Laborato
242.40
(5.33%)

Apollo Hospitals Ent
276.55
(4.33%)

Sun Pharmaceutical I
48.40
(2.91%)

Metropolis Healthcar
70.65
(3.45%)

Piramal Pharma Ltd.
0.25
(0.15%)

Wockhardt Ltd.
-8.95
(-1.04%)

Aurobindo Pharma Ltd
24.05
(1.77%)

Alkem Laboratories L
119.40
(2.31%)

Laurus Labs Ltd.
16.35
(3.78%)

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us

Add Dr. Lal Pathlabs Ltd. to your Portfolio
Date of purchase
Quantity
Purchase price
Exchange	BSE BSE NSE NSE

Dr. Lal Pathlabs Ltd.

Dr. Lal Pathlabs Ltd.

News for Dr. Lal Pathlabs Ltd.

Financial Results of Dr. Lal Pathlabs Ltd.

About Dr. Lal Pathlabs Ltd.

News for Pharmaceuticals and health care

Top News

Report Card

BSE Announcements from Dr. Lal Pathlabs Ltd. (See all)

Compare 'Dr. Lal Pathlabs Ltd.' with other stocks

Mutual Funds Invested

Most Active

REDIFFGURUS

Hi, I am employed in Maldives from last one year and...

My husband is 50 and I am 47. We have a combined...

I am in a big debt trap. Have credit card...

Hi I am 40 year old married with no kids and no...

I have hdfc small cap, multicap, flexicap funds all...

I am due to retire on Jan2025.At present i hav got...

Sir, I had initially started SIP in mutual funds via...

Dr. Lal Pathlabs Ltd. performance snapshot

Peers

Stocks

Mutual Funds

Investment tracking

Add Dr. Lal Pathlabs Ltd. to your Portfolio

Add Dr. Lal Pathlabs Ltd. to your Watchlist

Add Dr. Lal Pathlabs Ltd. to your Watchlist Alert me if price...
Goes above Rs.
Goes below Rs.